Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-06

Clinical Trial Update: Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated temozolomide, bevacizumab, and lithium in combination with radiation for high-grade glioma; the study was terminated and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Lithium carbonate (Lithium carbonate)
  • Temodar (Temozolomide)

Snippet

Sponsor: NYU Langone Health | Conditions: Brain Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-11-06